Medicines under evaluation

This page lists information on applications for centralised marketing authorisations for human medicines that are under evaluation by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).

The list of medicines under evaluation is updated each month. It includes the international non-proprietary names (INN) and therapeutic areas for all new innovative medicines under evaluation by the CHMP. For generic and biosimilar medicines, it includes the INN (active moiety only, with no information on salt, ester or derivative) and therapeutic area.

2018

2017

2016

2015

2014

2013

2012

How useful was this page?

Add your rating